H. Lundbeck A/S (Lundbeck) today announced results from a long-term follow-up in patients who have received bexicaserin (LP352) for up to two years. Bexicaserin is a novel, investigational drug for ...
Davar also mentions that, “Some toothpastes still contain microbeads that could lead to exposure [to microplastics].” And ...
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...
Two years after the death of “Friends” star Matthew Perry, a court in California has sentenced one of his doctors to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback